FDA Decentralized Guidance with Ted Barduson PART 1
Dec 16 2024
Length: 17 mins
Podcast

Failed to add items

Sorry, we are unable to add the item because your shopping cart is already at capacity.

Add to basket failed.

Please try again later

Add to wishlist failed.

Please try again later

Remove from wishlist failed.

Please try again later

Adding to library failed

Please try again

Follow podcast failed

Unfollow podcast failed

FDA Decentralized Guidance with Ted Barduson PART 1

Listen for free

View show details

Summary
In this episode, we dive into the latest FDA guidance expanding flexibility for clinical trials by allowing healthcare providers (HCPs) to conduct visits under Principal Investigator (PI) oversight. What does this mean for patients, research sites, and sponsors? Join us as we sit down with Ted Barduson, COO and Co-founder of Medvector to discuss the practical implications of this groundbreaking change. From improving patient access and engagement to navigating oversight and compliance, we explore how this new guidance can reshape the clinical trial landscape. Tune in for insights and actionable tips to put this into practice at your site.

Show More Show Less

Only £0.99 a month for the first 3 months. Pay £0.99 for the first 3 months, and £7.99/month thereafter. Renews automatically. Terms apply. Start my membership

Show More Show Less

What listeners say about FDA Decentralized Guidance with Ted Barduson PART 1

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.co.uk reviews

Amazon reviews

No Reviews are Available

Report a review on Amazon